Trial · NCT02946073
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Titration Phase | STARTED | CAM2038 q1w or q4w BPN Treatment- Double Blind Phase | 811 | |
| Titration Phase | STARTED | Placebo Subcutaneous Injections-Double Blind Phase | 0 | |
| Titration Phase | STARTED | De Novo Subjects-Open Label Phase | 98 | |
| Titration Phase | STARTED | Rollover Subjects-Open Label | 0 | |
| Titration Phase | COMPLETED | CAM2038 q1w or q4w BPN Treatment- Double Blind Phase | 222 | |
| Titration Phase | COMPLETED | Placebo Subcutaneous Injections-Double Blind Phase | 0 | |
| Titration Phase | COMPLETED | De Novo Subjects-Open Label Phase | 75 | |
| Titration Phase | COMPLETED | Rollover Subjects-Open Label | 0 | |
| Titration Phase | NOT COMPLETED | CAM2038 q1w or q4w BPN Treatment- Double Blind Phase | 589 | |
| Titration Phase | NOT COMPLETED | Placebo Subcutaneous Injections-Double Blind Phase | 0 | |
| Titration Phase | NOT COMPLETED | De Novo Subjects-Open Label Phase | 23 | |
| Titration Phase | NOT COMPLETED | Rollover Subjects-Open Label | 0 | |
| Double Blind Phase | STARTED | CAM2038 q1w or q4w BPN Treatment- Double Blind Phase | 112 | |
| Double Blind Phase | STARTED | Placebo Subcutaneous Injections-Double Blind Phase | 110 | |
| Double Blind Phase | STARTED | De Novo Subjects-Open Label Phase | 0 | |
| Double Blind Phase | STARTED | Rollover Subjects-Open Label | 0 | |
| Double Blind Phase | COMPLETED | CAM2038 q1w or q4w BPN Treatment- Double Blind Phase | 88 | |
| Double Blind Phase | COMPLETED | Placebo Subcutaneous Injections-Double Blind Phase | 70 | |
| Double Blind Phase | COMPLETED | De Novo Subjects-Open Label Phase | 0 | |
| Double Blind Phase | COMPLETED | Rollover Subjects-Open Label | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02946073/flow